Why Your Surgeon Mentioned EuroSCORE II — and Why It Matters to You
If you or someone you love is facing heart surgery, you may have heard the term "EuroSCORE" in a conversation with your surgical team. Perhaps it appeared on a consultation report or was referenced when your surgeon explained the risks of your procedure. Whatever the context, this number carries real weight — it influences whether you are offered surgery, which type of procedure is recommended, and how your care team prepares for the operation.
The EuroSCORE II calculator is a risk prediction tool used by cardiac surgeons across the globe. Originally developed in Europe, it estimates the likelihood of dying during or shortly after heart surgery based on a set of patient-specific variables. As a cardiac surgeon, I use risk scores like EuroSCORE II alongside the STS score every day to help patients understand their individual risk profile. But I have also seen how confusing — and sometimes alarming — these numbers can be when patients encounter them without proper context.
This article is designed to give you that context. I want you to understand what the EuroSCORE II is measuring, where it does well, where it falls short, and how it should factor into the decisions you are making right now.
How the European Cardiac Surgery Risk Score Actually Works
EuroSCORE stands for European System for Cardiac Operative Risk Evaluation. The original version (EuroSCORE I) was introduced in 1999 based on data from nearly 20,000 patients across 128 hospitals in eight European countries. It was groundbreaking at the time — one of the first validated tools that could translate a patient's clinical profile into a numerical mortality risk estimate.
By 2011, the surgical landscape had changed considerably. Patients were older, sicker, and undergoing more complex procedures. The original model was consistently overestimating risk, sometimes dramatically. So the developers updated it using a newer dataset of over 22,000 patients from 154 hospitals across 43 countries. The result was EuroSCORE II, which remains in wide clinical use today.
What Variables Does EuroSCORE II Include?
The EuroSCORE II calculator factors in 18 variables grouped into three categories:
- Patient-related factors: Age, sex, kidney function (creatinine clearance), presence of chronic lung disease, extracardiac arteriopathy (vascular disease outside the heart), poor mobility, prior cardiac surgery, active endocarditis, and whether the patient has a critical preoperative state (such as requiring IV medications to maintain blood pressure).
- Cardiac-related factors: Left ventricular function (ejection fraction), recent heart attack, pulmonary artery pressure, and whether there is unstable angina.
- Surgery-related factors: Urgency of the operation (elective, urgent, emergent, or salvage), the type and number of procedures being performed, and whether surgery involves the thoracic aorta.
Each variable is weighted differently within a logistic regression model. The output is a predicted risk of in-hospital mortality — expressed as a percentage. For example, a EuroSCORE II of 2.5% means the model estimates a 2.5% chance of dying during or immediately after surgery.
If you want to see how risk calculators work in practice, you can explore our free cardiac surgery risk calculator, which helps you put these numbers in perspective.
EuroSCORE vs STS: Understanding the Two Major Risk Scoring Systems
One of the most common questions I hear from patients — especially those who have done their own research — is about the difference between EuroSCORE vs STS risk scores. Both are widely used, but they are not interchangeable, and understanding the differences can help you interpret the numbers your surgeon shares with you.
Key Differences at a Glance
- Database origin: EuroSCORE II was developed primarily from European patient data. The STS (Society of Thoracic Surgeons) score is built from North American surgical outcomes data — one of the largest clinical databases in the world, with records from millions of procedures.
- Procedure specificity: The STS score has separate, validated models for coronary artery bypass grafting (CABG), isolated valve surgery, and combined valve-plus-CABG procedures. EuroSCORE II uses a single model that covers all adult cardiac surgical procedures, with procedure type as one of its input variables.
- Outcome measures: EuroSCORE II predicts in-hospital mortality. The STS score predicts operative mortality (death within 30 days or during the same hospitalization) and also provides estimates for major morbidity outcomes — including stroke, prolonged ventilation, kidney failure, deep sternal wound infection, and reoperation. This additional granularity is one of the STS score's major advantages.
- Calibration and updates: The STS score is recalibrated periodically using contemporary data from its national database. EuroSCORE II has not undergone a formal recalibration since its 2011 release, though it has been externally validated in numerous international studies.
Which Score Is More Accurate?
This depends on the clinical scenario and the patient population. Multiple validation studies — including a widely cited 2014 analysis published in the European Journal of Cardiothoracic Surgery — have shown that EuroSCORE II performs reasonably well for average-risk patients but can lose accuracy at the extremes. Specifically, it has been shown to underestimate risk in very high-risk patients and overestimate risk in low-risk cohorts in certain settings.
The STS score, because it is procedure-specific and regularly recalibrated, tends to have better discrimination and calibration for North American populations undergoing common operations like isolated CABG or aortic valve replacement. For patients being evaluated for transcatheter procedures like TAVR, both scores are used — but the STS-PROM (Predicted Risk of Mortality) has become the de facto benchmark in the United States for categorizing patients as low, intermediate, or high surgical risk per ACC/AHA guidelines.
In my practice, I look at both. When there is a meaningful discrepancy between EuroSCORE II and STS — and there sometimes is — that becomes a conversation with the patient about which factors may be driving the difference and what the clinical implications are.
Where EuroSCORE II Helps — and Where Patients Should Be Cautious
No risk model is perfect. Every score is a population-level estimate applied to an individual — and that inherent tension means you should never let a single number dictate your decision.
Strengths of EuroSCORE II
- Broadly applicable: Because it uses a single model across procedure types, it can provide an estimate even for less common or combined operations where STS-specific models may not apply.
- Internationally validated: EuroSCORE II has been tested in patient populations across Europe, Asia, South America, and the Middle East, making it relevant for patients receiving care outside the United States.
- Useful for initial risk stratification: It provides a quick, structured snapshot that helps surgical teams categorize risk and guide the heart team discussion about the best treatment approach.
Limitations Patients Should Know
- It does not capture everything: Frailty, nutritional status, liver disease severity, porcelain aorta, and specific anatomical details (like the extent of coronary disease or the complexity of valve pathology) are not included. These factors matter enormously in real-world surgical decision-making.
- Aging data: The 2011 development cohort may not fully reflect current surgical techniques, perioperative care, or patient demographics. Surgical outcomes have improved significantly in many areas since then.
- Single-outcome focus: Knowing your risk of dying is important, but it is not the only thing that matters. What about your risk of stroke? Of prolonged ICU stay? Of needing dialysis? EuroSCORE II does not answer these questions. The STS score does, which is one reason many U.S. surgeons rely on it more heavily.
- Potential miscalibration in specific subgroups: Studies have shown variable performance in patients with infective endocarditis, those undergoing redo operations, and elderly patients with multiple comorbidities. If you fall into one of these categories, the number on the page may not accurately represent your individual risk.
This is exactly why context matters, and why a second set of expert eyes on your case can be invaluable. If you have been quoted a risk score that seems very high — or surprisingly low — and you are unsure whether the recommendation you have received is the right one, consider getting a cardiac surgery second opinion from a board-certified surgeon who can review your specific imaging, labs, and clinical history.
How to Use Your EuroSCORE II as a Patient
Here is my practical advice for patients who have been given a EuroSCORE II or who are trying to understand their risk profile before cardiac surgery:
1. Ask your surgeon to explain the score in the context of your specific case. A EuroSCORE II of 4% means something different for an 80-year-old undergoing redo aortic valve surgery than it does for a 65-year-old having first-time CABG. The same number, in different clinical contexts, may represent an excellent result or a serious concern.
2. Ask whether the STS score has also been calculated. If you are having surgery in the United States and the procedure is one for which an STS model exists (CABG, aortic valve replacement, mitral valve surgery), you should expect to see the STS-PROM and STS morbidity estimates. If only EuroSCORE II was provided, ask why.
3. Understand that the score is a starting point, not a verdict. Risk models inform decisions; they do not make them. Your surgeon's experience, the hospital's volume and outcomes, and your own values and goals all play critical roles in determining the right path forward.
4. Do not compare your score to someone else's. Every patient's physiology, anatomy, and life circumstances are unique. A friend who had a lower score and a good outcome does not invalidate your concerns, and a high score does not mean the operation is not worth pursuing.
5. If the numbers do not feel right, get a second opinion. I say this not as a marketing pitch but as a clinical principle. Some of the most impactful second opinions I have provided involved patients whose risk scores were misinterpreted — either leading to unnecessary fear or to premature dismissal of a surgical option that could have helped them.
Risk Scores Are Tools — Not Decisions
The EuroSCORE II calculator is a valuable instrument in the cardiac surgeon's toolkit. It provides a structured, evidence-based estimate that helps teams communicate risk and plan care. But it is one data point among many. It does not account for the full complexity of who you are as a patient — your resilience, your support system, your goals, or the nuances of your anatomy that only become clear on careful review of your imaging and catheterization data.
As a surgeon, I have operated on patients with high EuroSCORE II values who did beautifully, and I have seen patients with low scores encounter unexpected complications. The score frames the conversation. It does not end it.
What ends the conversation — or rather, what should guide it — is a thorough, individualized evaluation by an experienced cardiac surgical team. And if you have any doubt about whether the evaluation you have received meets that standard, it is worth seeking another perspective.
If you are facing a cardiac surgery decision and want to understand what your EuroSCORE II or STS risk score truly means for your case, a WhiteGloveMD second opinion can help. Our AI-assisted review process, led by a board-certified cardiovascular surgeon, analyzes your complete medical record — including imaging, catheterization results, lab work, and risk scores — and provides a clear, written assessment of your surgical options, individualized risk, and recommended next steps. You can learn more about how our process works or start your review today.